Results 211 to 220 of about 141,530 (342)

Association between Premorbid Renin-Angiotensin-Aldosterone System Blockade and the Risk of Acute Kidney Injury in Critically Ill Patients. [PDF]

, 2023
Ruey‐Hsing Chou, Shang‐Feng Yang, Cheng-Hsueh Wu, Yi‐Lin Tsai, Ya‐Wen Lu, Jiun‐Yu Guo, Po‐Hsun Huang, Shing‐Jong Lin   +7 more
openalex   +1 more source

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 579-588, February 2026.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman, Victoria E. Parker, Carmel M. McEniery, Giovanni Di Stefano, Annette Hubsch, Evangelia Vamvaka, Jo Helmy, Fotini Kaloyirou, Navazh Jalaludeen, Peter Barker, Lutz Jermutus, Joseph Cheriyan, Philip Ambery, Ian B. Wilkinson   +13 more
wiley   +1 more source

Total serum T3 and T4 in nontoxic goiter and autonomous adenoma [PDF]

, 1972
Borowzak, H., Habermann, J., Horn, K., Retting, M., Ruhl, T., Scriba, Peter Christian   +5 more
core   +1 more source

Idiopathic orthostatic hypotension: Recent data (eleven cases) and review of the literature [PDF]

Eight cases of Shy-Drager syndrome and three of Bradbury-Eggleston idiopathic orthostatic hypotension were examined. In all cases, examination of circulatory reflexes showed major dysfunction of the sympathetic vasoconstrictor system.
Annat, G., Boisson, D., Devic, M., Holzhapfel, L., Levrat, R., Michel, D., Ninet, J., Peyrin, L., Schott, B., Vincent, M.   +9 more
core   +1 more source

Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity

, 2023
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernández-Llimós   +3 more
openalex   +1 more source

Machine learning methods for predicting adverse drug events: A systematic review

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 422-444, February 2026.
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, Sheikh S. Abdullah, Neda Rostamzadeh, Atefeh Jafari, Lujain Izzedin, Kamran Sedig, Flory T. Muanda   +8 more
wiley   +1 more source

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases

, 2014
Miklós Fagyas, Úri Katalin, Ivetta Mányiné Siket, Andrea Daragó, Judit Boczán, Emese Bányai, István Édes, Zoltán Papp, Attila Tóth   +8 more
openalex   +2 more sources

The renin-angiotensin-aldosterone system and cardiac ischaemia [PDF]

, 1996
Hamid Ikram
openalex   +1 more source

Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences [PDF]

, 2021
Agnieszka Dettlaff‐Pokora, Julian Świerczyński   +1 more
openalex   +1 more source

Targeting the Renin-Angiotensin-Aldosterone System in Fibrosis.

Matrix Biology, 2020
Mohammed Alqudah, T. Hale, M. Czubryt
semanticscholar   +1 more source